Global Healthcare Industry M&A and Capital Market Landscape Review

This report provides an analysis of the global healthcare mergers and acquisitions (M&A) and capital market landscape for the first half of 2025. It outlines the cautious approach adopted by investors amid market volatility, highlighting a slowdown in deal activity as private equity players focus on bolt-on acquisitions and strategic buyers prioritize mid-market transactions. The report discusses the impact of trade tensions and pricing pressures on valuations, resulting in fewer large agreements. It also examines the Debt Capital Market's slowdown due to increased market volatility and the shift in equity deals, particularly IPOs, as investors become more risk-averse. The report emphasizes the growing importance of environmental, social, and governance (ESG) factors in M&A, noting that companies with strong ESG profiles may experience lower capital costs. Looking ahead, the report anticipates an increase in deal activity, particularly in the pharma and biotech sectors, driven by available capital and the need for business model transformations.